News

PetVivo Holdings, Inc. (OTC: PETV) Q4 2025 Earnings Call Transcript June 30, 2025 ...
Industry veteran Catherine Owen Adams expects external innovation will be key to getting the brain-focused drug developer to “the next level.” ...
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...
When you stumble upon BagelTechNews.com Tech Secrets Revealed: Unlock Innovation Today, you probably wonder what kinda juicy ...
Cintas Corporation’s market leadership and growth are impressive, but valuation looks stretched with high P/E and PEG ratios.
Over 60 participants joined the second FAI Anti-Doping webinar of 2025: “Social Drugs and Air Sports: Make Sure You Fly Clean ...
Investors should pounce on this opportunity to buy the stock. Here are three reasons why. First, AstraZeneca continues to ...
Business Wire India Uniqus Consultech, a tech-enabled global platform that offers consulting solutions in the accounting & reporting, finance operations, governance, risk, ESG, an ...
DiGeorge syndrome, is a genetic disorder caused by a chromosome 22 deletion, presenting symptoms like heart defects, immune deficiencies, and developmental delays. Market growth is driven by ...